Literature DB >> 15059809

Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice.

Linda Persson1, Jan Borén, Anna-Karin L Robertson, Ville Wallenius, Göran K Hansson, Marcela Pekna.   

Abstract

OBJECTIVE: To investigate the effect of complement deficiency on atherogenesis and lipidemia, we used mice deficient in the third complement component (C3-/-) or factor B (FB-/-). METHODS AND
RESULTS: Complement-deficient mice were crossed with mice deficient in both apolipoprotein E and the low-density lipoprotein receptor (Apoe-/- LDLR-/-). The percent lesion area in the aorta at 16 weeks, determined by en face analysis, was 84% higher in C3-/- mice than in controls (11.8%+/-0.4% versus 6.4%+/-0.8%, mean+/-SEM, P<0.00005). The C3-/- mice also had 58% higher serum triglyceride levels (P<0.05) and a more proatherogenic lipoprotein profile, with significantly more low-density lipoprotein cholesterol and very-low-density lipoprotein triglycerides than control mice. The C3-/- mice weighed 13% less (P<0.01) and had a lower body fat content (3.5%+/-1.0% versus 13.1%+/-3.0%, P<0.01). There were no differences between FB-/- mice and controls.
CONCLUSIONS: Complement activation by the classical or lectin pathway exerts atheroprotective effects, possibly through the regulation of lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15059809     DOI: 10.1161/01.ATV.0000127302.24266.40

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  30 in total

1.  The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Talat H Malik; Andrea Cortini; Daniele Carassiti; Joseph J Boyle; Dorian O Haskard; Marina Botto
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

2.  Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Vinay K Bhatia; Sheng Yun; Viola Leung; David C Grimsditch; G Martin Benson; Marina B Botto; Joseph J Boyle; Dorian O Haskard
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice via the complement system.

Authors:  L Persson; J Borén; A Nicoletti; G K Hansson; M Pekna
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

4.  Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.

Authors:  Denis A Mogilenko; Igor V Kudriavtsev; Vladimir S Shavva; Ella B Dizhe; Ekaterina G Vilenskaya; Alexander M Efremov; Andrej P Perevozchikov; Sergey V Orlov
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

5.  Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages.

Authors:  Denis A Mogilenko; Igor V Kudriavtsev; Andrey S Trulioff; Vladimir S Shavva; Ella B Dizhe; Boris V Missyul; Alexander V Zhakhov; Alexander M Ischenko; Andrej P Perevozchikov; Sergey V Orlov
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

6.  Plasma Complement Protein C3a Level Was Associated with Abdominal Aortic Calcification in Patients on Hemodialysis.

Authors:  Yaqin Wang; Yuanyi Miao; Kunjing Gong; Xuyang Cheng; Yuqing Chen; Ming-Hui Zhao
Journal:  J Cardiovasc Transl Res       Date:  2019-04-15       Impact factor: 4.132

Review 7.  The role of complement activation in atherogenesis: the first 40 years.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Violeta Rus; Armugam P Mekala; Petru A Mircea; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

8.  CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.

Authors:  Guipeng An; Takashi Miwa; Wen-Liang Song; John A Lawson; Daniel J Rader; Yun Zhang; Wen-Chao Song
Journal:  Mol Immunol       Date:  2009-03-17       Impact factor: 4.407

9.  Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.

Authors:  Gongxiong Wu; Weiguo Hu; Aliakbar Shahsafaei; Wenping Song; Martin Dobarro; Galina K Sukhova; Rod R Bronson; Guo-Ping Shi; Russell P Rother; Jose A Halperin; Xuebin Qin
Journal:  Circ Res       Date:  2009-01-08       Impact factor: 17.367

10.  The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice.

Authors:  Ruth D Lewis; Christopher L Jackson; B Paul Morgan; Timothy R Hughes
Journal:  Mol Immunol       Date:  2009-12-02       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.